Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 4, 1997, Pages 361-367

  Aaser, E ^a   Gullestad, L ^a   Tollofsrud S ^a   Lundberg, J ^b   Hall, C ^a   Djoseland O ^a   Kjekshus, J ^a   Forfang, K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antidiuretic hormone; Big endothelin; Epinerphrine; Neuropeptide Y; Norepinephrine; pro ANF

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BIG ENDOTHELIN; CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; LISINOPRIL; NEUROPEPTIDE Y; NITRATE; NORADRENALIN; PROPEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN; WARFARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIET; DIURESIS; DRUG ADMINISTRATION; FEMALE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NATRIURESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

DIGITALIS;

EID: 0030852034     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709099409     Document Type: Article

References (20)

1. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982; 24: 437-59.
2. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Int Med 1984; 101: 370-7.
3. Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol 1986; 7: 758-65.
4. Goldstein DS. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol 1981; 48: 1147-54.
5. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23.
6. Westheim A, Os I, Thaulow E, Kjeldsen SE, Eritsland J, Eide IK. Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure. Clin Physiol 1992; 12: 95-106.
7. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989; 13: 1534-9.
8. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85: 1374-9.
9. Rodeheffer RJ, Lerman A, Heublein DM, Burnett Jr JC. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992; 67: 719-24.
10. Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 1986; 6: 561-78.
11. Andreasen F, Mikkelsen E. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 1977; 12: 15-22.
12. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
13. Lowe J, Gray J, Henry DA, Lawson DH. Adverse reactions to furosemide in hospital inpatients. Br Med J 1979; 2: 360-2.
14. Gallagher KL, Jones JK. Furosemide-induced ototoxicity. Ann Int Med 1979; 91: 744-5.
15. Gerlag PGG, van Meijel JJM. High-dose furosemide in the treatment of refractory congestive heart failure. Arch Int Med 1988; 148: 286-91.
16. Van Meyel JJM, Smits P, Dormans T, Gerlag PGG, Russel FGM, Gribnau FWJ. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Int Med 1994; 235: 329-34.
17. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57: 17-22.
18. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Int Med 1985; 103: 1-6.
19. Lahav M, Regev A, Ra'anani P, Theodor E. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992; 102: 725-31.
20. Dormans TPJ, Van Meyel JJM, Gerlag PGG, Yen Tan. Russel FGM, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996; 28: 376-82.